12h00: Richard AUSTIN “Caffeine reduces PCSK9 expression though its ability to regulate ER calcium/SREBP activation”
15h00: Richard AUSTIN “Role of the PCSK9-Q152H LOF variant in protection against liver injury and cardiometabolic disease”
15h20: Mathilde VARRET “The singular French PCSK9-p.Ser127Arg gain-of-function variant: A significant player in cholesterol levels from a 775-year-old common ancestor”
15h40: Mathilde VARRET “PCSK9 in SMC and atherosclerosis”
16h00:
16h20: Discussion Générale